Phase 3 FRESCO-2 Trial Analysis of Fruquintinib mCRC Colorectal 3 Mins Read5 The phase 3 FRESCO-2 study evaluated the efficacy and safety of fruquintinib, a novel targeted therapy, in patients with advanced…
